Adaptimmune Therapeutics (ADAP) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Adaptimmune Therapeutics (ADAP) will resume trading at 4:35pm ET
November 9, 2016 4:13 PM ESTAdaptimmune Therapeutics (NASDAQ: ADAP) will resume trading at 4:35pm EST.
... MoreAdaptimmune Therapeutics (ADAP) Announces Lift of FDA Partial Clinical Hold on NY‑ESO SPEAR in MRCLS
November 9, 2016 4:06 PM ESTAdaptimmune Therapeutics plc (Nasdaq: ADAP) announced that the U.S. Food and Drug Administration has removed the partial clinical hold on the planned study of its NYESO SPEAR (Specific Peptide Enhanced Affinity Receptor) T-cell therapy in MRCLS.
Under a revised protocol,... More
Adaptimmune Therapeutics (ADAP), Novavax (NVAX) trading halted with news pending.
November 9, 2016 4:01 PM ESTAdaptimmune Therapeutics (NASDAQ: ADAP), Novavax (NASDAQ: NVAX) trading halted with news pending.
... More